It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. The treatment, jointly developed with the Japanese company,

Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While regular screenings remain crucial,

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — including colorectal, gastric, kidney and liver cancer — is also on the rise, though cancer among patients under 50 is still relatively rare overall, Dr. Partridge said.

Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save lives. A new study recently showcased how AI can revolutionize breast cancer detection, improving accuracy and easing radiologists’ workload.

Morgan Pressel's 18th annual Morgan & Friends event raised a record $1,022,000 to support the fight against breast cancer. Pressel, 36, lost her mother Kathy to breast cancer in 2003, and her memory is at the heart of the mission.

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

If you have breast cancer, you will have changes in your breast. These may be lumps or changes in the size or color of your breast, or changes in the appearance of your nipples. Breast cancer ...

Vanessa Rissetto overcame incredible odds to secure millions in funding for Culina Health, a company transforming access to nutrition care.

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves patient outcomes.

Artificial Intelligence can improve breast cancer detection and reduce workload on physicians, according to a new study from Germany featuring over 461,000 women.